News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,526 Results
Type
Article (13932)
Company Profile (300)
Press Release (247294)
Section
Business (79349)
Career Advice (151)
Deals (13189)
Drug Delivery (34)
Drug Development (50323)
Employer Resources (31)
FDA (5681)
Job Trends (5114)
News (144123)
Policy (10018)
Tag
Academia (901)
Alliances (21517)
Alzheimer's disease (754)
Approvals (5657)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4519)
Biotechnology (245)
Breast cancer (109)
Cancer (875)
Cardiovascular disease (68)
Career advice (132)
CAR-T (70)
Cell therapy (211)
Clinical research (40096)
Collaboration (295)
Compensation (126)
COVID-19 (1005)
C-suite (78)
Cystic fibrosis (66)
Data (972)
Diabetes (83)
Diagnostics (1206)
Drug discovery (56)
Earnings (29001)
Events (47170)
Executive appointments (235)
FDA (6035)
Funding (297)
Gene editing (63)
Gene therapy (162)
GLP-1 (306)
Government (1064)
Healthcare (6542)
Infectious disease (1041)
Inflammatory bowel disease (98)
IPO (7195)
Job creations (859)
Job search strategy (127)
Layoffs (186)
Legal (1374)
Lung cancer (128)
Lymphoma (60)
Manufacturing (80)
Medical device (2559)
Medtech (2560)
Mergers & acquisitions (6122)
Metabolic disorders (248)
Neuroscience (993)
NextGen Class of 2024 (2000)
Non-profit (846)
Northern California (1076)
Obesity (135)
Opinion (91)
Parkinson's disease (73)
Patents (60)
People (25082)
Phase I (14130)
Phase II (18645)
Phase III (11811)
Pipeline (363)
Postmarket research (851)
Preclinical (5970)
Radiopharmaceuticals (205)
Rare diseases (198)
Real estate (1409)
Regulatory (8273)
Research institute (931)
Southern California (965)
Startups (1964)
United States (8524)
Vaccines (164)
Weight loss (78)
Date
Today (76)
Last 7 days (360)
Last 30 days (1559)
Last 365 days (20600)
2024 (20250)
2023 (22413)
2022 (26822)
2021 (27807)
2020 (23358)
2019 (16225)
2018 (11738)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16909)
Australia (2851)
California (2435)
Canada (792)
China (198)
Colorado (90)
Connecticut (101)
Europe (36423)
Florida (268)
Georgia (68)
Illinois (150)
Indiana (61)
Kansas (55)
Maryland (323)
Massachusetts (1923)
Minnesota (99)
New Jersey (617)
New York (672)
North Carolina (415)
Northern California (1076)
Ohio (82)
Pennsylvania (466)
South America (207)
Southern California (965)
Texas (273)
Washington State (244)
261,526 Results for "abeona therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abeona Therapeutics® Announces Participation in November 2024 Investor Conferences
November 5, 2024
·
2 min read
Policy
Abeona Therapeutics Provides Regulatory Update on Pz-cel
Abeona Therapeutics Inc. announced a regulatory update for prademagene zamikeracel.
April 22, 2024
·
6 min read
BioMidwest
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. Eastern Time.
May 28, 2024
·
3 min read
Press Releases
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
November 14, 2024
·
10 min read
Deals
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Abeona Therapeutics Inc. (Nasdaq: ABEO) (“Abeona” or the “Company”) today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock.
May 3, 2024
·
5 min read
Business
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2024 and recent corporate progress.
May 15, 2024
·
8 min read
Press Releases
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 2, 2024
December 3, 2024
·
3 min read
BioMidwest
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 03, 2024
Abeona Therapeutics Inc. announced it has granted equity awards to new non-executive employees who joined the Company.
June 3, 2024
·
3 min read
Policy
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data
The regulator on Monday slapped Abeona Therapeutics with a Complete Response Letter for its investigational cell therapy pz-cel due to chemistry, manufacturing and controls issues.
April 23, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
September 3, 2024
·
3 min read
1 of 26,153
Next
